Usenova A, Akhunbaev S, Tumanbaev A, Lim E
Asian Pac J Cancer Prev. 2023; 24(2):613-621.
PMID: 36853312
PMC: 10162603.
DOI: 10.31557/APJCP.2023.24.2.613.
Wu Y, Deng Y, Wei B, Xiang D, Hu J, Zhao P
J Adv Res. 2022; 40:233-247.
PMID: 35700919
PMC: 9481947.
DOI: 10.1016/j.jare.2022.06.001.
Chalmers I, Glasziou P
J R Soc Med. 2021; 114(11):507-512.
PMID: 34698579
PMC: 8649484.
DOI: 10.1177/01410768211051720.
Gargya V, Hoogendoorn J, Kahn A, Bascone C, Podda S
Plast Reconstr Surg Glob Open. 2020; 8(8):e3021.
PMID: 32983778
PMC: 7489719.
DOI: 10.1097/GOX.0000000000003021.
Vicente-Duenas C, Janssen S, Oldenburg M, Auer F, Gonzalez-Herrero I, Casado-Garcia A
Blood. 2020; 136(18):2003-2017.
PMID: 32911536
PMC: 7694022.
DOI: 10.1182/blood.2019004381.
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.
Zhou Y, Han C, Wang E, Lorch A, Serafin V, Cho B
Cancer Discov. 2020; 10(9):1388-1409.
PMID: 32444465
PMC: 7483384.
DOI: 10.1158/2159-8290.CD-19-1436.
Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.
Del Risco Kollerud R, Cannon-Albright L, Haugnes H, Ruud E, Thoresen M, Nafstad P
Pediatr Blood Cancer. 2020; 67(8):e28408.
PMID: 32437093
PMC: 7313725.
DOI: 10.1002/pbc.28408.
DNA damage signalling from the placenta to foetal blood as a potential mechanism for childhood leukaemia initiation.
Mansell E, Zareian N, Malouf C, Kapeni C, Brown N, Badie C
Sci Rep. 2019; 9(1):4370.
PMID: 30867444
PMC: 6416312.
DOI: 10.1038/s41598-019-39552-0.
Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study.
Steliarova-Foucher E, Fidler M, Colombet M, Lacour B, Kaatsch P, Pineros M
Lancet Oncol. 2018; 19(9):1159-1169.
PMID: 30098952
PMC: 6120055.
DOI: 10.1016/S1470-2045(18)30423-6.
A causal mechanism for childhood acute lymphoblastic leukaemia.
Greaves M
Nat Rev Cancer. 2018; 18(8):471-484.
PMID: 29784935
PMC: 6986894.
DOI: 10.1038/s41568-018-0015-6.
Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium.
Petridou E, Georgakis M, Erdmann F, Ma X, Heck J, Auvinen A
Eur J Epidemiol. 2018; 33(10):965-976.
PMID: 29761423
PMC: 6384148.
DOI: 10.1007/s10654-018-0402-z.
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
Bonaventure A, Harewood R, Stiller C, Gatta G, Clavel J, Stefan D
Lancet Haematol. 2017; 4(5):e202-e217.
PMID: 28411119
PMC: 5418564.
DOI: 10.1016/S2352-3026(17)30052-2.
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007.
Marcos-Gragera R, Galceran J, Martos C, de Munain A, Vicente-Raneda M, Navarro C
Clin Transl Oncol. 2016; 19(3):301-316.
PMID: 27447899
DOI: 10.1007/s12094-016-1531-z.
Prognostic Impact of WT-1 Gene Expression in Egyptian Children with Acute Lymphoblastic Leukemia.
Hagag A, Badraia I, Hassan S, El-Lateef A
Mediterr J Hematol Infect Dis. 2016; 8(1):e2016008.
PMID: 26740869
PMC: 4696468.
DOI: 10.4084/MJHID.2016.008.
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel A, Lafta F, Schwalbe E, Nakjang S, Cockell S, Iliasova A
Epigenetics. 2015; 10(8):717-26.
PMID: 26237075
PMC: 4622588.
DOI: 10.1080/15592294.2015.1061174.
Socioeconomic Status and Childhood Leukemia Incidence in Switzerland.
Adam M, Kuehni C, Spoerri A, Schmidlin K, Gumy-Pause F, Brazzola P
Front Oncol. 2015; 5:139.
PMID: 26175964
PMC: 4485172.
DOI: 10.3389/fonc.2015.00139.
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
Stamati L, Avgeris M, Kosmidis H, Baka M, Anastasiou T, Piatopoulou D
J Cancer Res Clin Oncol. 2015; 141(11):2023-36.
PMID: 25982455
DOI: 10.1007/s00432-015-1982-6.
Targeted nanoparticles for pediatric leukemia therapy.
Basha R, Sabnis N, Heym K, Bowman W, Lacko A
Front Oncol. 2014; 4:101.
PMID: 24860784
PMC: 4026702.
DOI: 10.3389/fonc.2014.00101.
Childhood cancer incidence in British Indians & Whites in Leicester, 1996-2008.
Sayeed S, Barnes I, Cairns B, Finlayson A, Ali R
PLoS One. 2013; 8(4):e61881.
PMID: 23613964
PMC: 3629092.
DOI: 10.1371/journal.pone.0061881.
Anti-leukemic response of a NSAID, tolfenamic acid.
Sutphin R, Connelly S, Lee C, Sankpal U, Eslin D, Khan M
Target Oncol. 2013; 9(2):135-44.
PMID: 23609055
DOI: 10.1007/s11523-013-0274-9.